 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$22.93 |
$23.07 |
$22.64 |
$22.70 |
1.78M | | 04/16/2024 |
$22.60 |
$23.08 |
$22.53 |
$22.82 |
1.69M | | 04/17/2024 |
$22.90 |
$23.29 |
$22.82 |
$22.87 |
2.80M | | 04/18/2024 |
$23.00 |
$23.23 |
$22.46 |
$22.49 |
2.61M | | 04/19/2024 |
$22.47 |
$22.71 |
$22.23 |
$22.52 |
2.33M |
|
|
| Exelixis is an oncology company that engages in creating medicines and combination regimens for cancer care. Co.'s products include: CABOMETYX® (cabozantinib) tablets, which are approved both alone and in combination with Bristol-Myers Squibb Company's OPDIVO® (nivolumab) for renal cell carcinoma; COMETRIQ® (cabozantinib) capsules, which are approved for progressive, metastatic medullary thyroid cancer; COTELLIC® (cobimetinib), an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of melanoma; and MINNEBRO® (esaxerenone), an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in Japan. | |
|
Exelixis (EXEL) has the following price history information. Looking back at EXEL historical stock prices for the last five trading days, on April 15, 2024, EXEL opened at $22.93, traded as high as $23.07 and as low as $22.64, and closed at $22.70. Trading volume was a total of 1.78M shares. On April 16, 2024, EXEL opened at $22.60, traded as high as $23.08 and as low as $22.53, and closed at $22.82. Trading volume was a total of 1.69M shares. On April 17, 2024, EXEL opened at $22.90, traded as high as $23.29 and as low as $22.82, and closed at $22.87. Trading volume was a total of 2.80M shares. On April 18, 2024, EXEL opened at $23.00, traded as high as $23.23 and as low as $22.46, and closed at $22.49. Trading volume was a total of 2.61M shares. On April 19, 2024, EXEL opened at $22.47, traded as high as $22.71 and as low as $22.23, and closed at $22.52. Trading volume was a total of 2.33M shares.
EXEL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Exelixis shares, starting with a $10,000 purchase of EXEL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$3.58 |
|
| End price/share: |
$22.52 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
529.05% |
|
| Average Annual Total Return: |
20.19% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$62,904.74 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/15/2024 | $22.70 | | 04/16/2024 | $22.82 | | 04/17/2024 | $22.87 | | 04/18/2024 | $22.49 | | 04/19/2024 | $22.52 |
|
|
Free EXEL Email Alerts:
